Treatment of metabolic syndrome

Details for Australian Patent Application No. 2003227683 (hide)

Owner PHARMACIA AB

Inventors Saller, Bernhard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003227683

PCT Number PCT/EP03/04357

PCT Pub. Number WO2003/090784

Priority 0209642.8 26.04.02 GB; 0218912.4 14.08.02 GB

Filing date 24 April 2003

Wipo publication date 10 November 2003

International Classifications

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61K 038/27 Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 031/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61P 005/50 Drugs for disorders of the endocrine system

A61P 005/00 Drugs for disorders of the endocrine system

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 0209642.8 26.04.02 GB; 0218912.4 14.08.02 GB

18 December 2003 Application Open to Public Inspection

  Published as AU-A-2003227683

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003227684-CATALYST AND METHOD FOR HYDROGENATING AROMATIC COMPOUNDS

2003227682-PROTECTIVE COATING COMPOSITION